DelveInsight’s, “Hepatic Tumor Pipeline Insight 2024”report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Hepatic Tumor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this […]
Antibiotics Market Global Antibiotics Market size was valued at USD 50.60 billion in 2022 and is poised to grow from USD 52.67 billion in 2023 to USD 72.65 billion by 2031, growing at a CAGR of 4.10% during the forecast period (2024-2031). Antibiotics Market was valued at USD 52.67 billion in 2023 to USD 72.65 billion […]
Ancestry India DNA – “One Test, Generations of Insight” Ancestry India DNA offers innovative DNA mapping and testing focused on accessible, personalized healthcare for Indian citizens. By providing insights into family health history, it helps prevent hereditary diseases and empowers individuals to make informed health decisions. With an emphasis on care and support, the company […]
DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights […]
The global chemiluminescence immunoassay market in terms of revenue was estimated to be worth $13.2 billion in 2023 and is poised to reach $19.0 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 Browse 181 market data Tables and 52 Figures spread through 283 Pages and in-depth TOC on “Chemiluminescence Immunoassay […]
Interstitial Cystitis Clinical Trials Interstitial Cystitis companies are Seikagaku Corporation, UCB, Alivio Therapeutics, Merck, Teva Pharmaceutical, Integrative Therapeutics, Lipella Pharmaceuticals, Addex Therapeutics, Imbrium Therapeutics, Ironwood Pharmaceuticals, others. (Albany, USA) DelveInsight’s, “Interstitial Cystitis Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Interstitial Cystitis pipeline landscape. It covers the pipeline drug profiles, including clinical […]
Interstitial Lung Disease Clinical Trials Interstitial Lung Disease companies are AstraZeneca, CSL Behring, Syndax Pharmaceuticals, Taiho Pharmaceutical, GenKyoTex, Kadmon Pharmaceuticals, Novartis, Ark Biosciences, Roche, PureTech Health, Avalyn Pharma, Bristol-Myers Squibb, Insmed, Bayer, HEC Pharm, Prometheus Biosciences, Boehringer Ingelheim, Genentech, FibroGen, Reata Pharmaceuticals, Regend Therapeutics, Beijing Continent Pharmaceutical, Avalyn Pharmaceuticals, aTyr Pharma, Bristol-Myers Squibb, and AdAlta, […]
Cervical Dysplasia Market In the 7MM, the United States has the highest number of incident cases of Cervical Dysplasia, accounting for approximately 52% of the total. Within this population, around 90% of cases are classified as CIN1. According to DelveInsight’s latest report, “Cervical Dysplasia Market Insights, Epidemiology and Market Forecast, 2034,” the Cervical Dysplasia market […]
Hypoparathyroidism Market Rising cases of hypoparathyroidism across different regions are driving the demand for advanced diagnostic and treatment options in the hypoparathyroidism market. This growing need is contributing to the overall expansion of the market. The Hypoparathyroidism Market Report 2034 by DelveInsight provides an in-depth analysis of current treatment practices for hypoparathyroidism, upcoming drugs in […]
Cardiol Therapeutics (NASDAQ: CRDL) recently showcased its groundbreaking Myocarditis treatment, CardiolRx™, on Fox Business’s Making Money with Charles Payne, highlighting the potential life-saving impact of this innovative therapy. In a dynamic show of market strength, Cardiol Therapeutics Inc. (NASDAQ: CRDL) has completed its pivotal Phase II MAvERIC-Pilot study, showcasing significant reductions in pain and inflammation for recurrent […]
